STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52

STRATA Skin Sciences, Inc. (NASDAQ:SSKN)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.52 and traded as high as $0.59. STRATA Skin Sciences shares last traded at $0.53, with a volume of 9,773 shares changing hands.

STRATA Skin Sciences Stock Performance

The company has a market cap of $18.58 million, a PE ratio of -1.71 and a beta of 1.58. The company has a current ratio of 1.28, a quick ratio of 1.06 and a debt-to-equity ratio of 1.19. The business has a fifty day moving average of $0.50 and a 200-day moving average of $0.52.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Wednesday, March 27th. The medical device company reported ($0.04) earnings per share (EPS) for the quarter. STRATA Skin Sciences had a negative net margin of 32.47% and a negative return on equity of 52.50%. The business had revenue of $8.69 million for the quarter. Equities research analysts anticipate that STRATA Skin Sciences, Inc. will post -0.19 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Chicago Partners Investment Group LLC grew its holdings in shares of STRATA Skin Sciences by 162.0% during the 4th quarter. Chicago Partners Investment Group LLC now owns 64,223 shares of the medical device company’s stock worth $33,000 after acquiring an additional 39,706 shares during the period. Azzad Asset Management Inc. ADV grew its holdings in shares of STRATA Skin Sciences by 289.5% during the 1st quarter. Azzad Asset Management Inc. ADV now owns 67,000 shares of the medical device company’s stock worth $25,000 after acquiring an additional 49,800 shares during the period. Finally, 22NW LP grew its holdings in shares of STRATA Skin Sciences by 56.1% during the 3rd quarter. 22NW LP now owns 5,369,954 shares of the medical device company’s stock worth $3,195,000 after acquiring an additional 1,930,693 shares during the period. Hedge funds and other institutional investors own 32.43% of the company’s stock.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.